Daniel Koller
Chief Investment Officer chez BB BIOTECH AG
Profil
Daniel Koller est responsable de BB Biotech chez Bellevue Asset Management AG et responsable de la gestion des investissements chez BB Biotech AG. Il a rejoint Bellevue Asset Management en 2004 et depuis 2010, il dirige la gestion de BB Biotech AG. Auparavant, il a été employé en tant que responsable de la conformité chez Oz Holding AG, investisseur en private equity chez Equity4life AG, analyste d'actions chez UBS Warburg, Inc. et auditeur chez Ernst & Young AG, ainsi que membre du conseil d'administration de Patrimonium Swiss Real Estate Fund. M. Koller est titulaire d'un master en biochimie de l'École polytechnique fédérale de Zurich (ETH) et d'un doctorat en biotechnologie de l'École polytechnique fédérale de Zurich (ETH) et de Cytos Biotechnology Ltd. Zurich.
Postes actifs de Daniel Koller
| Sociétés | Poste | Début |
|---|---|---|
| BB BIOTECH AG | Chief Investment Officer | 01/01/2004 |
Bellevue Asset Management AG
 Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Head-Equity Investments | 01/01/2010 |
Anciens postes connus de Daniel Koller
| Sociétés | Poste | Fin |
|---|---|---|
| BELLEVUE GROUP AG | Director of Finance/CFO | 28/02/2019 |
| VALARTIS GROUP AG | Compliance Officer | 01/01/2005 |
| Equity4life AG | Corporate Officer/Principal | 01/01/2004 |
Ernst & Young AG
 Ernst & Young AG Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young AG is a Swiss company that provides accounting services. The private company is based in Zurich, Switzerland. | Corporate Officer/Principal | 01/01/2004 |
| UBS Warburg, Inc. | Analyst-Equity | 31/12/2000 |
Formation de Daniel Koller
| Swiss Federal Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BB BIOTECH AG | Finance |
| VALARTIS GROUP AG | Finance |
| BELLEVUE GROUP AG | Finance |
| Entreprise privées | 5 |
|---|---|
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Finance |
| Equity4life AG | Miscellaneous |
Ernst & Young AG
Ernst & Young AG Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young AG is a Swiss company that provides accounting services. The private company is based in Zurich, Switzerland. | Commercial Services |
| UBS Warburg, Inc. | |
Patrimonium Swiss Real Estate Fund
 Patrimonium Swiss Real Estate Fund Investment Trusts/Mutual FundsMiscellaneous Patrimonium Swiss Real Estate Fund operates as a closed-end investment fund. It invests in residential and mixed properties with a focus on residential properties in the moderate-rent segment, mainly in the Lake Geneva region and the Fribourg, Bern, Baser and Zug axis. The company was founded on November 20, 2007 and is headquartered in Crissier, Switzerland. | Miscellaneous |
